04150 Use of hormonal contraceptives and menopausal replacement therapy in women with acute porphyria

11.9%) with intravenous glucose/dextrose, 6 (5.5%) with carbohydrate intake and 4 (3.7%) with other medications.Conclusions The demographic and clinical characteristics of the patients enrolled in ELEVATE underscore the heterogeneous nature of AHP.The registry data collected will provide real-world evidence on the natural history and treatment of patients, helping to improve the clinical management of AHP.Safety and effectiveness endpoints will be analyzed in the future, during ongoing data collection as part of a postauthorization commitment.